Lehdistötiedote16.07.2026 klo 11.40Novakand Pharma Provides an Operational Update Regarding Management, Website, and Planned Extraordinary General Meeting
Lehdistötiedote25.06.2026 klo 16.00Novakand Pharma consolidates forces for the development of orphan drugs against cancer
Lehdistötiedote31.03.2026 klo 09.00Novakand Pharma to hold Extraordinary General Meeting to decide on future business direction – Comments from the board of directors
Lehdistötiedote02.03.2026 klo 08.00Novakand’s Board of Directors proposes new business direction and relisting to be presented at Extraordinary General Meeting
Lehdistötiedote25.02.2026 klo 17.45The board evaluates Novakand Pharma’s options after the decision not to execute the planned reverse take over of SVF Vaccines
Lehdistötiedote12.02.2026 klo 18.45Novakand Pharma applies for Nasdaq’s approval of continued listing of the combined company post a completed reverse takeover with SVF Vaccines
Lehdistötiedote06.02.2026 klo 09.00Novakand Pharma enters into share purchase agreement with SVF Vaccines regarding a reverse takeover
Pörssitiedote22.12.2025 klo 09.00Novakand Pharma enters Letter of Intent with SVF Vaccines regarding a reverse takeover
Pörssitiedote21.11.2025 klo 09.00Interim Report Third Quarter 2025, July 1 – September 30 Novakand Pharma AB (publ.), org.no. 556806-8851
Lehdistötiedote09.10.2025 klo 10.00Novakand Pharma provides an update on the ongoing reverse take over process
Pörssitiedote23.09.2025 klo 16.00Peter Selin resigns as CEO of Novakand Pharma in mutual agreement with the board
Pörssitiedote18.09.2025 klo 19.00Kancera initiates process to seek stakeholders for a reverse take over
Pörssitiedote28.08.2025 klo 09.00Interim Report First Quarter 2025, April 1 – June 30 Kancera AB (publ.), org.no. 556806-8851
Lehdistötiedote16.06.2025 klo 09.30Kancera announces rugocrixan and fosrugocrixan as the International Non-proprietary Names for KAND567 and KAN145
Pörssitiedote23.05.2025 klo 09.00Interim Report First Quarter 2025, January 1 – March 31 Kancera AB (publ.), org.no. 556806-8851